Vaccine Research
Synthetic Vaccine Developed
Published in Vaccine Weekly, November 24th, 1997
The vaccine, which contains no biologically derived components, could represent the first stage in the development of a new generation "minimalist" vaccines with potentially fewer side-effects than their conventional counterparts.
The work, carried out by a team led by Dr. Geert-Jan Boons, is partly funded by the Engineering and Physical Sciences Research Council.
While synthetic vaccines are unlikely to become available for several years, the research has demonstrated that it should be feasible to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1997-11-24)
More Articles from Vaccine Weekly
- HIV Vaccines
AIDS Vaccine Proposal Due - Amebiasis (Conference News)
Test Available to Distinguish Parasite Species - Cancer Vaccines
GM-CSF-Transduced Tumor Vaccine Effect in Murine Leukemia Model - Cancer Vaccines (Conference News)
Allogeneic Vaccines May Be Viable Alternative to Autologous Vaccines - Cancer Vaccines (Conference News)
Modified Vaccinia Vector Shows Promise As Cancer Vaccine - Conference Coverage (ICAAC)
Syphilis Vaccine Remains Elusive Despite Advances - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
